In the second proposed mechanism, SPARC expression in prostate tumor cells induces an increase in VEGF expression, which upregulates VEGF binding to VEGFR2 present on the tumor cells, thereby promoting tumor growth.42 However, the authors found the opposite results using M21 melanoma cells and suggested that these differences are because of the cell type-specific differences. The gene discussed is SPARC; the disease is neoplasm.